Rapid assembly of customized TALENs into multiple

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Zhang, Zhengxing ^a,c   Zhang, Siliang ^a   Huang, Xin ^a,b   Orwig, Kyle E ^a   Sheng, Yi ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^c FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; DEAD BOX PROTEIN; NUCLEASE; TRANSCRIPTIONAL ACTIVATOR LIKE EFFECTOR NUCLEASE; UNCLASSIFIED DRUG; ENDONUCLEASE; FLUORESCENT DYE; GENOMIC DNA; PROTEIN D1PAS1; PROTEIN DDX3X; PROTEIN DDX3Y; TRANSCRIPTION ACTIVATOR LIKE EFFECTOR NUCLEASE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DDX3 GENE; EXPRESSION VECTOR; GENE; GENE DELIVERY SYSTEM; GENE MUTATION; GENETIC TRANSDUCTION; MALE; MOUSE; MUTATIONAL ANALYSIS; NONHUMAN; PLASMID; SEQUENCE ANALYSIS; TRANSPOSON; ADENOVIRIDAE; ANIMAL; CHEMISTRY; DRUG DELIVERY SYSTEM; GENE VECTOR; GENETICS; METABOLISM; PROCEDURES; GATEWAY ENTRY VECTOR; GENE CASSETTE; GENE FUNCTION; GENE TARGETING; GENETIC RECOMBINATION; GENETIC TRANSFECTION; MULTIGENE FAMILY; PIGGYBAC TRANSPOSON; REPORTER GENE; REPRESSOR GENE; TRANSCRIPTION INITIATION; VIRAL GENE DELIVERY SYSTEM;

ADENOVIRIDAE; ANIMALS; DRUG DELIVERY SYSTEMS; ENDONUCLEASES; GENETIC VECTORS; MICE;

EID: 84892416132     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0080281     Document Type: Article

References (69)

1. Friddle CJ, Abuin A, Ramirez-Solis R, Richter LJ, Buxton EC et al. (2003) High-throughput mouse knockouts provide a functional analysis of the genome. Cold Spring Harb Symp Quant Biol 68: 311-315. doi: 10.1101/sqb.2003.68.311. PubMed: 15338631.
2. Zambrowicz BP, Sands AT (2003) Knockouts model the 100 bestselling drugs - will they model the next 100? Nat Rev Drug Discov 2: 38-51. doi:10.1038/nrd987. PubMed: 12509758.
3. Gaj T, Gersbach CA, Barbas CF 3rd (2013) ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering. Trends Biotechnol, 31: 397-405. PubMed: 23664777.
4. Doyle EL, Stoddard BL, Voytas DF, Bogdanove AJ (2013) TAL effectors: highly adaptable phytobacterial virulence factors and readily engineered DNA-targeting proteins. Trends Cell Biol, 23: 390-8. PubMed: 23707478.
5. Sun N, Zhao H (2013) Transcription activator-like effector nucleases (TALENs): A highly efficient and versatile tool for genome editing. Biotechnol Bioeng, 110: 1811-21. PubMed: 23508559.
6. Sung YH, Baek IJ, Seong JK, Kim JS, Lee HW (2012) Mouse genetics: catalogue and scissors. BMB Rep 45: 686-692. doi:10.5483/BMBRep.2012.45.12.242. PubMed: 23261053.
7. Cathomen T, Joung JK (2008) Zinc-finger nucleases: the next generation emerges. Mol Ther 16: 1200-1207. doi:10.1038/mt.2008.114. PubMed: 18545224.
8. Takeuchi R, Lambert AR, Mak AN, Jacoby K, Dickson RJ et al. (2011) Tapping natural reservoirs of homing endonucleases for targeted gene modification. Proc Natl Acad Sci U S A 108: 13077-13082. doi:10.1073/pnas. 1107719108. PubMed: 21784983.
9. Baxter S, Lambert AR, Kuhar R, Jarjour J, Kulshina N et al. (2012) Engineering domain fusion chimeras from I-OnuI family LAGLIDADG homing endonucleases. Nucleic Acids Res 40: 7985-8000. doi:10.1093/nar/gks502. PubMed: 22684507.
10. Taylor GK, Petrucci LH, Lambert AR, Baxter SK, Jarjour J et al. (2012) LAHEDES: the LAGLIDADG homing endonuclease database and engineering server. Nucleic Acids Res 40: W110-W116. doi:10.1093/nar/gks326. PubMed: 22570419.
11. Jacoby K, Metzger M, Shen BW, Certo MT, Jarjour J et al. (2012) Expanding LAGLIDADG endonuclease scaffold diversity by rapidly surveying evolutionary sequence space. Nucleic Acids Res 40: 4954-4964. doi:10.1093/nar/gkr1303. PubMed: 22334611.
12. Boch J, Scholze H, Schornack S, Landgraf A, Hahn S et al. (2009) Breaking the code of DNA binding specificity of TAL-type III effectors. Science 326: 1509-1512. doi:10.1126/science.1178811. PubMed: 19933107.
13. Moscou MJ, Bogdanove AJ (2009) A simple cipher governs DNA recognition by TAL effectors. Science 326: 1501. doi:10.1126/science.1178817. PubMed: 19933106.
14. Bogdanove AJ, Voytas DF (2011) TAL effectors: customizable proteins for DNA targeting. Science 333: 1843-1846. doi:10.1126/science.1204094. PubMed: 21960622.
15. Sanjana NE, Cong L, Zhou Y, Cunniff MM, Feng G et al. (2012) A transcription activator-like effector toolbox for genome engineering. Nat Protoc 7: 171-192. doi:10.1038/nprot.2011.431. PubMed: 22222791.
16. Reyon D, Tsai SQ, Khayter C, Foden JA, Sander JD et al. (2012) FLASH assembly of TALENs for high-throughput genome editing. Nat Biotechnol 30: 460-465. doi:10.1038/nbt.2170. PubMed: 22484455.
17. Mussolino C, Morbitzer R, Lütge F, Dannemann N, Lahaye T et al. (2011) A novel TALE nuclease scaffold enables high genome editing activity in combination with low toxicity. Nucleic Acids Res 39: 9283-9293. doi:10.1093/nar/gkr597. PubMed: 21813459.
18. Cermak T, Doyle EL, Christian M, Wang L, Zhang Y et al. (2011) Efficient design and assembly of custom TALEN and other TAL effector-based constructs for DNA targeting. Nucleic Acids Res 39: e82. doi:10.1093/nar/gkr218. PubMed: 21493687.
19. Sun N, Liang J, Abil Z, Zhao H (2012) Optimized TAL effector nucleases (TALENs) for use in treatment of sickle cell disease. Mol Biosyst 8: 1255-1263. doi:10.1039/c2mb05461b. PubMed: 22301904.
20. Miller JC, Tan S, Qiao G, Barlow KA, Wang J et al. (2011) A TALE nuclease architecture for efficient genome editing. Nat Biotechnol 29: 143-148. doi:10.1038/nbt.1755. PubMed: 21179091.
21. Chen S, Oikonomou G, Chiu CN, Niles BJ, Liu J et al. (2013) A large-scale in vivo analysis reveals that TALENs are significantly more mutagenic than ZFNs generated using context-dependent assembly. Nucleic Acids Res 41: 2769-2778. doi:10.1093/nar/gks1356. PubMed: 23303782.
22. Zhang Y, Zhang F, Li X, Baller JA, Qi Y et al. (2013) Transcription activator-like effector nucleases enable efficient plant genome engineering. Plant Physiol 161: 20-27. doi:10.1104/pp.112.205179. PubMed: 23124327.
23. Li T, Liu B, Spalding MH, Weeks DP, Yang B (2012) High-efficiency TALEN-based gene editing produces disease-resistant rice. Nat Biotechnol 30: 390-392. doi:10.1038/nbt.2199. PubMed: 22565958.
24. Li T, Huang S, Zhao X, Wright DA, Carpenter S et al. (2011) Modularly assembled designer TAL effector nucleases for targeted gene knockout and gene replacement in eukaryotes. Nucleic Acids Res 39: 6315-6325. doi:10.1093/nar/ gkr188. PubMed: 21459844.
25. Liu J, Li C, Yu Z, Huang P, Wu H et al. (2012) Efficient and specific modifications of the Drosophila genome by means of an easy TALEN strategy. J Genet Genomics 39: 209-215. doi:10.1016/j.jgg.2012.04.003. PubMed: 22624882.
26. Ansai S, Sakuma T, Yamamoto T, Ariga H, Uemura N et al. (2013) Efficient targeted mutagenesis in medaka using custom-designed transcription activator-like effector nucleases. Genetics 193: 739-749. doi:10.1534/genetics. 112.147645. PubMed: 23288935.
27. Zu Y, Tong X, Wang Z, Liu D, Pan R et al. (2013) TALEN-mediated precise genome modification by homologous recombination in zebrafish. Nat Methods 10: 329-331. doi:10.1038/nmeth.2374. PubMed: 23435258.
28. Moore FE, Reyon D, Sander JD, Martinez SA, Blackburn JS et al. (2012) Improved somatic mutagenesis in zebrafish using transcription activator-like effector nucleases (TALENs). PLOS ONE 7: e37877. doi:10.1371/journal.pone. 0037877. PubMed: 22655075.
29. Sakuma T, Hosoi S, Woltjen K, Suzuki K, Kashiwagi K et al. (2013) Efficient TALEN construction and evaluation methods for human cell and animal applications. Genes Cells 18: 315-326. doi:10.1111/gtc.12037. PubMed: 23388034.
30. Cristea S, Freyvert Y, Santiago Y, Holmes MC, Urnov FD et al. (2013) In vivo cleavage of transgene donors promotes nuclease-mediated targeted integration. Biotechnol Bioeng 110: 871-880. doi:10.1002/bit.24733. PubMed: 23042119.
31. Wang H, Hu YC, Markoulaki S, Welstead GG, Cheng AW et al. (2013) TALEN-mediated editing of the mouse Y chromosome. Nat Biotechnol, 31: 530-2. PubMed: 23666012.
32. Bedell VM, Wang Y, Campbell JM, Poshusta TL, Starker CG et al. (2012) In vivo genome editing using a high-efficiency TALEN system. Nature 491: 114-118. doi:10.1038/nature11537. PubMed: 23000899.
33. Sung YH, Baek IJ, Kim DH, Jeon J, Lee J et al. (2013) Knockout mice created by TALEN-mediated gene targeting. Nat Biotechnol 31: 23-24. doi:10.1038/nbt.2477. PubMed: 23302927.
34. Tesson L, Usal C, Ménoret S, Leung E, Niles BJ et al. (2011) Knockout rats generated by embryo microinjection of TALENs. Nat Biotechnol 29: 695-696. doi:10.1038/nbt.1940. PubMed: 21822240.
35. Carlson DF, Tan W, Lillico SG, Stverakova D, Proudfoot C et al. (2012) Efficient TALEN-mediated gene knockout in livestock. Proc Natl Acad Sci U S A 109: 17382-17387. doi:10.1073/pnas.1211446109. PubMed: 23027955.
36. Kim Y, Kweon J, Kim A, Chon JK, Yoo JY et al. (2013) A library of TAL effector nucleases spanning the human genome. Nat Biotechnol 31: 251-258. doi:10.1038/nbt.2517. PubMed: 23417094.
37. Ding Q, Lee YK, Schaefer EA, Peters DT, Veres A et al. (2013) A TALEN genome-editing system for generating human stem cell-based disease models. Cell Stem Cell 12: 238-251. doi:10.1016/j.stem. 2012.11.011. PubMed: 23246482.
38. Schmid-Burgk JL, Schmidt T, Kaiser V, Höning K, Hornung V (2013) A ligation-independent cloning technique for high-throughput assembly of transcription activator-like effector genes. Nat Biotechnol 31: 76-81. PubMed: 23242165.
39. Stroud DA, Formosa LE, Wijeyeratne XW, Nguyen TN, Ryan MT (2013) Gene knockout using transcription activator-like effector nucleases (TALENs) reveals that human NDUFA9 protein is essential for stabilizing the junction between membrane and matrix arms of complex I. J Biol Chem 288: 1685-1690. doi:10.1074/jbc.C112.436766. PubMed: 23223238.
40. Choi SM, Kim Y, Shim JS, Park JT, Wang RH et al. (2013) Efficient drug screening and gene correction for treating liver disease using patient-specific stem cells. Hepatology, 57: 2458-68. PubMed: 23325555.
41. Zhang F, Cong L, Lodato S, Kosuri S, Church GM et al. (2011) Efficient construction of sequence-specific TAL effectors for modulating mammalian transcription. Nat Biotechnol 29: 149-153. doi:10.1038/nbt.1775. PubMed: 21248753.
42. Geissler R, Scholze H, Hahn S, Streubel J, Bonas U et al. (2011) Transcriptional activators of human genes with programmable DNA-specificity. PLOS ONE 6: e19509. doi:10.1371/journal.pone.0019509. PubMed: 21625585.
43. Cong L, Zhou R, Kuo YC, Cunniff M, Zhang F (2012) Comprehensive interrogation of natural TALE DNA-binding modules and transcriptional repressor domains. Nat Commun 3: 968. doi:10.1038/ncomms1962. PubMed: 22828628.
44. Jinek M, Chylinski K, Fonfara I, Hauer M, Doudna JA et al. (2012) A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 337: 816-821. doi:10.1126/science.1225829. PubMed: 22745249.
45. Mali P, Yang L, Esvelt KM, Aach J, Guell M et al. (2013) RNA-guided human genome engineering via Cas9. Science 339: 823-826. doi:10.1126/science.1232033. PubMed: 23287722.
46. Cong L, Ran FA, Cox D, Lin S, Barretto R et al. (2013) Multiplex genome engineering using CRISPR/Cas systems. Science 339: 819-823. doi:10.1126/science. 1231143. PubMed: 23287718.
47. Wang H, Yang H, Shivalila CS, Dawlaty MM, Cheng AW et al. (2013) One-Step Generation of Mice Carrying Mutations in Multiple Genes by CRISPR/Cas-Mediated Genome Engineering. Cell, 153: 910-8. PubMed: 23643243.
48. Fu Y, Foden JA, Khayter C, Maeder ML, Reyon D et al. (2013) High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells. Nat Biotechnol, 31: 822-6. PubMed: 23792628.
49. Engler C, Marillonnet S (2011) Generation of families of construct variants using golden gate shuffling. Methods Mol Biol 729: 167-181. doi:10.1007/978-1-61779-065-2-11. PubMed: 21365490.
50. Walhout AJ, Temple GF, Brasch MA, Hartley JL, Lorson MA et al. (2000) GATEWAY recombinational cloning: application to the cloning of large numbers of open reading frames or ORFeomes. Methods Enzymol 328: 575-592. doi:10.1016/S0076-6879(00)28419-X. PubMed: 11075367.
51. Hartley JL, Temple GF, Brasch MA (2000) DNA cloning using in vitro site-specific recombination. Genome Res 10: 1788-1795. doi:10.1101/gr.143000. PubMed: 11076863.
52. Holkers M, Maggio I, Liu J, Janssen JM, Miselli F et al. (2013) Differential integrity of TALE nuclease genes following adenoviral and lentiviral vector gene transfer into human cells. Nucleic Acids Res 41: e63. doi:10.1093/nar/gks1029. PubMed: 23275534.
53. Cheo DL, Titus SA, Byrd DR, Hartley JL, Temple GF et al. (2004) Concerted assembly and cloning of multiple DNA segments using in vitro site-specific recombination: functional analysis of multi-segment expression clones. Genome Res 14: 2111-2120. doi:10.1101/gr.2512204. PubMed: 15489333.
54. Uhde-Stone C, Gor N, Chin T, Huang J, Lu B (2013) A do-it-yourself protocol for simple transcription activator-like effector assembly. Biol Proced Online 15: 3. doi:10.1186/1480-9222-15-3. PubMed: 23316790.
55. Zhang Z, Li D, Xu H, Xin Y, Zhang T et al. (2013) A simple and efficient method for assembling TALE protein based on plasmid library. PLOS ONE 8: e66459. doi:10.1371/journal.pone.0066459. PubMed: 23840477.
56. Weber E, Gruetzner R, Werner S, Engler C, Marillonnet S (2011) Assembly of designer TAL effectors by Golden Gate cloning. PLOS ONE 6: e19722. doi:10.1371/journal.pone.0019722. PubMed: 21625552.
57. Christian ML, Demorest ZL, Starker CG, Osborn MJ, Nyquist MD et al. (2012) Targeting G with TAL effectors: a comparison of activities of TALENs constructed with NN and NK repeat variable di-residues. PLOS ONE 7: e45383. doi:10.1371/journal.pone.0045383. PubMed: 23028976.
58. Hu R, Wallace J, Dahlem TJ, Grunwald DJ, O'Connell RM (2013) Targeting Human MicroRNA Genes Using Engineered Tal-Effector Nucleases (TALENs). PLOS ONE 8: e63074. doi:10.1371/journal.pone.0063074. PubMed: 23667577.
59. Mashimo T, Kaneko T, Sakuma T, Kobayashi J, Kunihiro Y et al. (2013) Efficient gene targeting by TAL effector nucleases coinjected with exonucleases in zygotes. Sci Rep 3: 1253. PubMed: 23409244.
60. Davies B, Davies G, Preece C, Puliyadi R, Szumska D et al. (2013) Site Specific Mutation of the Zic2 Locus by Microinjection of TALEN mRNA in Mouse CD1, C3H and C57BL/6J Oocytes. PLOS ONE 8: e60216. doi:10.1371/journal.pone. 0060216. PubMed: 23555929.
61. Qiu Z, Liu M, Chen Z, Shao Y, Pan H et al. (2013) High-efficiency and heritable gene targeting in mouse by transcription activator-like effector nucleases. Nucleic Acids Res, 41: e120-. PubMed: 23630316.
62. Li T, Yang B (2013) TAL effector nuclease (TALEN) engineering. Methods Mol Biol 978: 63-72. doi:10.1007/978-1-62703-293-3-5. PubMed: 23423889.
63. Alba R, Bosch A, Chillon M (2005) Gutless adenovirus: last-generation adenovirus for gene therapy. Gene Ther 12 Suppl 1: S18-S27. doi: 10.1038/sj.gt.3302612. PubMed: 16231052.
64. Li R, Zhuang Y, Han M, Xu T, Wu X (2013) piggyBac as a high-capacity transgenesis and gene-therapy vector in human cells and mice. Dis Model. J Mech 6: 828-833.
65. Rostovskaya M, Naumann R, Fu J, Obst M, Mueller D et al. (2013) Transposon mediated BAC transgenesis via pronuclear injection of mouse zygotes. Genesis 51: 135-141. doi:10.1002/dvg.22362. PubMed: 23225373.
66. Rostovskaya M, Fu J, Obst M, Baer I, Weidlich S et al. (2012) Transposon-mediated BAC transgenesis in human ES cells. Nucleic Acids Res 40: e150. doi:10.1093/nar/gks643. PubMed: 22753106.
67. Li MA, Turner DJ, Ning Z, Yusa K, Liang Q et al. (2011) Mobilization of giant piggyBac transposons in the mouse genome. Nucleic Acids Res 39: e148. doi:10.1093/nar/gkr764. PubMed: 21948799.
68. Li M, Izpisua Belmonte JC (2012) No factor left behind: generation of transgene-free induced pluripotent stem cells. Am J Stem Cells 1: 75-80. PubMed: 23671799.
69. Li MA, Pettitt SJ, Eckert S, Ning Z, Rice S et al. (2013) The piggyBac transposon displays local and distant reintegration preferences and can cause mutations at noncanonical integration sites. Mol Cell Biol 33: 1317-1330. doi:10.1128/MCB.00670-12. PubMed: 23358416.